Method:98 cases of patients with chronic prostatitis (post-STD) enrolled in this group received Tamsulosin hydrochloride, urethral instillation of mixed solution of antibiotics, and physical therapy with TRM-2Z(L) Multi-functional prostate therapy device.
Methods 160 cases were randomly divided into two groups, of whom 96 cases of chronic bacterial prostatitis were treated by an innovated prostatic treatment instrument, as treatment group, and 64 cases were treated with oral administration of medicine, as control group.
Results The prostatic treatment instrument for the patients with chronic bacterial prostatitis is an effective, safe, comfortable and scientific new method of endourethal treatment.
20 patients have been followed the treatment was 5. 08ml/s,being 10. 6ml/s after 3 months and 14. 6ml/s after 6months. Transrectal B-ultrasonography has been carried out for l4 patients and the echo from the treated prostatic area was markedly diminished. The lumen of the posterior urethra was dilated.
Methods:176 patients with chronic prostatitis were treated with inflating drug perfusion through prostate perfusion catheter in combination with physical therapy by multifunction prostate therapeutic instrument.
Objective: To assess the clinic efficacy and safety in the treatment of chronic abacterial prostatitis/chronic pelvic pain syndrome(CABP/CPPS) after intraprostatic injection of Chuanshentong.
Conclusions:Therapy of chronic prostatitis with prostate perfusion catheter perfusion method in combination with physical therapy by multifunction prostate therapeutic instrument is one of the important therapies available for chronic prostatitis with the advantages of high effectiveness and less complication.
rom June to Sep. l993,interstitial laser coagulation (ILC)with Dornir(MBB) 177 was adopted for the treatment of 24 cases of prostatic hyperplasia, usually 5 minutes irradiation for each lobe. No continuous irrigation was required during the procedure. 20 patients have been followed the treatment was 5. 08ml/s,being 10. 6ml/s after 3 months and 14. 6ml/s after 6months.Transrectal B-ultrasonography has been carried out for l4 patients and the echo from the treated prostatic area was markedly diminished.The lu...
AbstractAgroup of 53 patients with benign prostatic hy-perplasia underwent transrectal hyperthermia usingProstathermer(Biodan)from September 1992 to March1993.41 of the 53 patients were followed up for 6months. The subjective symptoms improved in 75.6%(31/41)of the treated patients.The mean maximumurine flow rate increased bv 3.1±2. 6ml/s.The meanresidual urine reduced 38.4±25.2ml.The meanprostate volume remained almost unchanged.The re-sults showed that transrectal hyperthermia of theprostate gland is as e...
The therapy principle and design of microwave prostate hyperthermia are described. This apparatus uses 915MHz microwave treatment for the prostate. The solid state microwave source and surface cooling system of special design only heats the prostate. The specially designed Foley duct and microwave radiator can be used for treatment by transurethral or transrectal. The temperature is measured and monitered automatically, and the measured data are recorded, displayed and printed in real-time by a microcompute...